BioSpace News Archive

Biotech Beach

Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2020

Neurocrine Biosciences, Inc. will present at the Bank of America Merrill Lynch Health Care Conference 2020 at 2:20 p.m. ET on Tuesday, May 12, 2020.

May 5, 2020
·
1 min read
Business

Rigel Reports First Quarter 2020 Financial Results and Provides Business Update

Rigel Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2020, including sales of TAVALISSE® tablets, for the treatment of adults with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.

May 5, 2020
·
14 min read
Business

Akcea Reports Financial Results and Highlights for First Quarter 2020

Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing medicines to treat patients with serious and rare diseases, reported financial results for the first quarter ended March 31, 2020.

May 5, 2020
·
12 min read
Business

Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020

Invitae Corporation, a leading medical genetics company, announced financial and operating results for the first quarter ended March 31, 2020.

May 5, 2020
·
12 min read
Business

Vapotherm Reports First Quarter 2020 Financial Results

Vapotherm, Inc.,, a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced first quarter 2020 financial results.

May 5, 2020
·
17 min read
Business

Acorda Reports First Quarter 2020 Financial Results and Provides Business Update

Acorda Therapeutics, Inc. provided a business update and reported its financial results for the first quarter ended March 31, 2020.

May 5, 2020
·
11 min read
Business

Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results

Company Updates Guidance and Clinical Development Timeline in Response to the COVID-19 Global Pandemic

May 5, 2020
·
11 min read
Business

Clovis Oncology Announces First Quarter 2020 Operating Results

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended March 31, 2020, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook for the rest of the year.

May 5, 2020
·
16 min read
Business

Cardiovascular Systems, Inc. Reports Fiscal 2020 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal third quarter, ended March 31, 2020.

May 5, 2020
·
19 min read
Business

Quanterix Corporation Releases Operating Results for First Quarter 2020

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three months ended March 31, 2020.

May 5, 2020
·
8 min read